Tanaka Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.47M | Sell |
110,854
-230
| -0.2% | -$8.6K | 7.46% | 3 |
|
|
2025
Q4 | $3.87M | Sell |
111,084
-125
| -0.1% | -$9.82K | 7.05% | 4 |
|
|
2025
Q3 | $9.24M | Buy |
+111,209
| New | +$8.05M | 16.64% | 1 |
|
|
2025
Q1 | $10.6M | Sell |
93,184
-18,367
| -16% | -$1.12M | 25.34% | 1 |
|
|
2024
Q4 | $5.62M | Sell |
111,551
-585
| -0.5% | -$30.7K | 12.85% | 2 |
|
|
2024
Q3 | $5.19M | Buy |
112,136
+11,860
| +12% | +$421K | 12% | 2 |
|
|
2024
Q2 | $3.26M | Buy |
100,276
+9,400
| +10% | +$257K | 7.71% | 5 |
|
|
2024
Q1 | $2.29M | Buy |
90,876
+53,785
| +145% | +$1.27M | 5.63% | 6 |
|
|
2023
Q4 | $1.21M | Sell |
37,091
-478
| -1% | -$13.1K | 2.95% | 9 |
|
|
2023
Q3 | $1.02M | Buy |
37,569
+2,030
| +6% | +$58.8K | 2.93% | 9 |
|
|
2023
Q2 | $791K | Hold |
35,539
| – | – | 2.14% | 13 |
|
|
2023
Q1 | $770K | Hold |
35,539
| – | – | 2.24% | 14 |
|
|
2022
Q4 | $722K | Hold |
35,539
| – | – | 2.29% | 13 |
|
|
2022
Q3 | $911K | Hold |
35,539
| – | – | 2.72% | 11 |
|
|
2022
Q2 | $845K | Sell |
35,539
-3,750
| -10% | -$81.7K | 2.75% | 11 |
|
|
2022
Q1 | $885K | Sell |
39,289
-230
| -0.6% | -$4.89K | 1.79% | 15 |
|
|
2021
Q4 | $782K | Sell |
39,519
-525
| -1% | -$10.7K | 1.49% | 20 |
|
|
2021
Q3 | $788K | Hold |
40,044
| – | – | 1.12% | 20 |
|
|
2021
Q2 | $881K | Hold |
40,044
| – | – | 1.19% | 16 |
|
|
2021
Q1 | $953K | Sell |
40,044
-110
| -0.3% | -$2.94K | 1.21% | 16 |
|
|
2020
Q4 | $1.05M | Sell |
40,154
-160
| -0.4% | -$3.37K | 2.33% | 9 |
|
|
2020
Q3 | $702K | Sell |
40,314
-21,540
| -35% | -$343K | 2.2% | 14 |
|
|
2020
Q2 | $1.04M | Sell |
61,854
-3,755
| -6% | -$52.8K | 3.22% | 11 |
|
|
2020
Q1 | $780K | Sell |
65,609
-4,040
| -6% | -$50K | 3.41% | 11 |
|
|
2019
Q4 | $843K | Sell |
69,649
-4,490
| -6% | -$62.5K | 2.67% | 12 |
|
|
2019
Q3 | $1.05M | Sell |
74,139
-2,685
| -3% | -$33K | 3.38% | 10 |
|
|
2019
Q2 | $857K | Sell |
76,824
-2,750
| -3% | -$30.6K | 2.63% | 18 |
|
|
2019
Q1 | $934K | Sell |
79,574
-8,430
| -10% | -$105K | 2.82% | 14 |
|
|
2018
Q4 | $1.18M | Sell |
88,004
-150
| -0.2% | -$1.98K | 3.74% | 10 |
|
|
2018
Q3 | $1.24M | Hold |
88,154
| – | – | 2.87% | 12 |
|
|
2018
Q2 | $1.39M | Sell |
88,154
-56,448
| -39% | -$982K | 3.32% | 12 |
|
|
2018
Q1 | $2.38M | Buy |
144,602
+4,320
| +3% | +$80K | 5.69% | 5 |
|
|
2017
Q4 | $2.53M | Buy |
140,282
+415
| +0.3% | +$7.52K | 5.78% | 6 |
|
|
2017
Q3 | $2.7M | Buy |
139,867
+470
| +0.3% | +$7.01K | 6.02% | 6 |
|
|
2017
Q2 | $1.65M | Buy |
139,397
+53,692
| +63% | +$584K | 3.77% | 10 |
|
|
2017
Q1 | $939K | Sell |
85,705
-1,610
| -2% | -$14.1K | 2.07% | 18 |
|
|
2016
Q4 | $634K | Buy |
+87,315
| New | +$684K | 1.48% | 23 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
Tanaka Capital Management's CORT Position: Q1 2026 in Review
Tanaka Capital Management reduced its Corcept Therapeutics (CORT) stake by 0.21% in Q1 2026, selling an estimated $8.6K and leaving 110,854 shares worth $4.47M. The position accounts for 7.46% of the portfolio, ranked #3.
Tanaka Capital Management first reported a position in CORT in Q4 2016 and has held it in 37 quarters since. The position peaked at $10.6M in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- Tanaka Capital Management held 110,854 shares of Corcept Therapeutics worth $4.47M as of Q1 2026.
- Tanaka Capital Management sold 230 Corcept Therapeutics shares in Q1 2026, an estimated $8.6K.
- Corcept Therapeutics made up 7.46% of Tanaka Capital Management's portfolio in Q1 2026, its #3 holding.
- Tanaka Capital Management first reported a position in Corcept Therapeutics in Q4 2016 and has held it in 37 quarters since.
- Tanaka Capital Management's Corcept Therapeutics position peaked at $10.6M in Q1 2025.
- 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on Tanaka Capital Management's 13F filing for Q1 2026, filed 18 May 2026.